NCT03313895

Brief Summary

This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease \[AD\] signature cortical thickness, and default mode network \[DMN\]) in older adults with amnestic MCI (aMCI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 18, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

July 5, 2018

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2024

Completed
Last Updated

April 25, 2025

Status Verified

August 1, 2024

Enrollment Period

6 years

First QC Date

October 6, 2017

Last Update Submit

April 23, 2025

Conditions

Keywords

Alzheimer's diseaseexercisecognitive trainingimaging

Outcome Measures

Primary Outcomes (6)

  • Executive function

    EXAMINER

    Change from baseline to 3, 6, 12, and 18 months

  • Episodic memory

    RAVLT and BVMTR

    Change from baseline to 3, 6, 12, and 18 months

  • AD-signature cortical thickness

    Magnetic Resonance Imaging (MRI)

    Change from baseline to 6, 12, and 18 months

  • Functional connectivity in DMN

    Functional MRI for Default Mode Network

    Change from baseline to 6, 12, and 18 months

  • Aerobic fitness

    VO2peak from symptom-limited peak cycle-ergometer test, and 10-m Incremental Shuttle Walk Test

    Change from baseline to 3, 6, 12, and 18 months

  • Conversion to Alzheimer's disease

    Clinical adjudication of Alzheimer's disease dementia

    Change from baseline to 6, 12, and 18 months

Study Arms (4)

Cycling Only

ACTIVE COMPARATOR

Moderate-intensity cycling, 3 times a week for 6 months, supervised by an exercise specialist

Behavioral: Cycling Only

Cognitive Training Only

ACTIVE COMPARATOR

Computerized cognitive training, 3 times a week for 6 months, supervised by a specialist

Behavioral: Cognitive Training Only

ACT

EXPERIMENTAL

Moderate-intensity cycling followed by computerized cognitive training, 3 times a week for 6 months, supervised by a specialist

Behavioral: Aerobic & Cognitive Training (ACT)

Stretching and Mental Stimulation Activities

SHAM COMPARATOR

Stretching and mental stimulation activities, 3 times a week for 6 months, supervised by a specialist

Behavioral: Stretching and Mental Stimulating Activities

Interventions

ACT stands for combined aerobic exercise and cognitive training.

ACT
Cycling OnlyBEHAVIORAL

Cycling on a recumbent stationary cycle

Cycling Only

Engage in cognitive training on a computer

Cognitive Training Only

Stretching exercises and mental stimulating activities on a computer

Stretching and Mental Stimulation Activities

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • A clinical diagnosis of MCI
  • Community-dwelling
  • Age 65 years and older
  • English-speaking
  • Adequate visual acuity
  • Verified exercise safety by medical provider
  • Stable on drugs affecting cognitive and psychological status
  • Verified MRI safety
  • Capacity to consent

You may not qualify if:

  • Geriatric Depression Scale \< 5
  • Resting heart rate (HR) ≤50 due to arrhythmia or ≥100 beats/min
  • Neurological (e.g., dementia, head trauma), psychiatric (e.g., bipolar, schizophrenia, or depression), or substance dependency (alcohol or chemical dependency) in the past 5 years that are the main contributor to MCI
  • Contraindications to exercise, e.g. unstable angina, recent surgery
  • New symptoms or diseases that have not been evaluated by a health care provider
  • Current enrollment in another intervention study related to cognitive improvement (reduce confounding effects on outcomes)
  • Abnormal MRI findings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Arizona State University

Phoenix, Arizona, 85004, United States

Location

Stanford University

Stanford, California, 94305, United States

Location

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

University of Rochester

Rochester, New York, 14642, United States

Location

Related Publications (4)

  • Derboghossian G, Pituch K, Anthony M, Salisbury D, Lin FV, Yu F. Relationships among cardiorespiratory fitness, brain age, and neurodegeneration in older adults with amnestic mild cognitive impairment. J Alzheimers Dis. 2025 Jun;105(3):945-954. doi: 10.1177/13872877251333613. Epub 2025 Apr 22.

  • Salisbury DL, Lin FV, Yu F. Testing the iMplementation Framework fOr behavioral and LIfestyLe interventions in AlZheimer's DiseasE (MOBILIZE) via the ACT randomized controlled trial. Sci Rep. 2025 Feb 13;15(1):5341. doi: 10.1038/s41598-025-88890-9.

  • Li D, Mielke MM, Bell WR, Reilly C, Zhang L, Lin FV, Yu F. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial). Trials. 2020 Jan 6;21(1):19. doi: 10.1186/s13063-019-3798-1.

  • Yu F, Lin FV, Salisbury DL, Shah KN, Chow L, Vock D, Nelson NW, Porsteinsson AP, Jack C Jr. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial. Trials. 2018 Dec 22;19(1):700. doi: 10.1186/s13063-018-3054-0.

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseMotor Activity

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesBehavior

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Fang Yu, PhD

    Arizona State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2017

First Posted

October 18, 2017

Study Start

July 5, 2018

Primary Completion

July 17, 2024

Study Completion

July 17, 2024

Last Updated

April 25, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations